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Role of integrins in mesangial cells adhesion to vitronectin and von
Willebrand factor. This study demonstrates (by flow cytometry and
immunoprecipitation after cell surface radiolabeling and by using mono-
clonal antibodies to a, f3, and aI3 and aj35 complexes) that avf3, the
vitronectin receptor, and Ov13 are expressed in vitro on cultured human
mesangial cells (HMC) of the 5th to 8th passages. Antibodies to a, 13 and
0V133 respectively precipitated an afl heterodimer with molecular weights
of 140 and 97 kDa. We analyzed the role of the various integrins in HMC
interactions with vitronectin, and with fIbronectin and von Willebrand
factor (vWf), which are synthetized respectively by mesangial and endo-
thelial cells. Cell adhesion increased in a dose dependent manner with the
concentration of plastic-coated matrix protein and vWf. Inhibition of cell
attachment with monoclonal antibodies to integrins indicated that HMC
adhesion to vWf primarily involves a(33, and that aj35 may also contribute
to cell binding to vWf. Adhesion to vitronectin involves both zj33 and c3
complexes. In contrast, adhesion to fibronectin was not affected by
monoclonal antibodies to a(33 and a13 complexes. We propose that
integrins av(33 and af35, present on HMC, could mediate an interaction
between mesangial and endothelial cells by binding to vWf, released at the
basal site of endothelial cells.
Integrins are heterodimeric transmembrane glycoproteins con-
sisting of varying combinations of noncovalently bound a and )3
chains, and are involved in adhesive interactions with the extra-
cellular matrix. They are critical for normal physiological pro-
cesses such as embryonic development, tissue structure and
wound repair [1].
Integrins that contain the a chain mediate attachment of a
variety of cells to diverse matrix proteins [2] and are critical for
angiogenesis [3, 4], migration [5], cell proliferation and survival
[6—8]. The integrin a/33, the vitronectin receptor, is the most
promiscuous member of the integrin family, allowing cells to
interact with a wide variety of proteins including vitronectin,
fibrinogen, von Willebrand factor, thrombospondin, fibronectin,
osteopontin, laminin and denatured collagen types I and IV [2].
avPs is expressed on a various of cells including endothelial cells,
fibroblasts, melanoma, osteosarcoma and smooth muscle cells. In
addition to p,a chain associates with multiple f3 chains, that is,
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l3, 135, 136 and [38. The nature of cellular interactions with matrix
proteins apparently depends on the /3 subunit. a131 and a135
recognize fibronectin and vitronectin [9], while a,j36 binds to
fibronectin [10, 11] and aj38 binds to vitronectin [12].
The renal localization of 13 integrins has been investigated in
developing and adult kidneys [13—15]. In the human adult glomer-
ulus, af33 is normally strongly expressed by glomerular endothe-
hal cells, capsular epithelial cells and podocytes, and to a lesser
extent by mesangial cells [13—18]. In the developing glomeruli, the
J3 chain is expressed in the cells of Bowman's capsule [19]. The
role of a/33 in the metanephric development is suggested by its
spatio-temporal distribution that varies with time, is restricted to
the epithelia before vascularization, and is concentrated in the
glomerular and extraglomerular vasculature in the mature kidney
[19].
In the present study, we investigated the presence and the
adhesive function of the a.,, family of integrins on human mesan-
gial cells in culture. We present evidence that a133 and a135 and
possibly a131 integrins are expressed at the membrane of this cell
type. We also show that adhesion of cultured HMC to vitronectin
and to vWf involves ai33 and af35.
Methods
Antibodies
The antibodies used in this study are presented in Table 1.
Monoclonal antibodies included: anti-a (clone AMF/7), an-
ti-a6 (clone GoH3), anti-a2 (clone Gi9), anti-/31 (clone Lia 1/2)
and control mouse IgO were from Immunotech (Marseille,
France); anti-a3 (clone P1B5) was from Chemicon (Temecula,
CA, USA); anti-a5 (clone 11, 16) was a generous gift from Dr.
Steven K. Akiyama (Laboratory of Developmental Biology, NIH,
MD, USA); anti-a (clone LM142, ascites) and anti-a133 (clone
LM 609, ascites) were a generous gift from Dr. David Cheresh
(Scripps Research Institute, La Jolla, CA, USA); anti-(33 (clone
AP3, ascites) was a generous gift from Dr. Peter J. Newman (The
Blood Center of Southeastern, WI, USA); anti-J31 (clone K20)
was a generous gift from Dr. Alain Bernard (INSERM U 343,
Nice, France); anti-a[35 (clone P1F6) was from Chemicon; FITC-
goat anti-mouse F(ah')2 IgG fragments were from Jackson IRL
(West Grove, PA, USA). The concentration for maximal mono-
clonal antibody binding was determined individually by flow
cytometry and excess concentrations were used, as indicated,
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Table 1. Antibodies to integrins used in this study
Specificity Clone Species Reference
a, Gi9 mouse [201
P1B5' mouse [21]
II mouse [22]
16° mouse
a6 GoH3° rat [23]
AMF7 mouse [24]
LM142 mouse [251
Lial/2 mouse [26]
1(20 mouse [271
AP3 mouse [281
polyclonal rabbit [29]
LMbO9° mouse [25]
a35 PIF6 mouse [30]
Antibodies known to inhibit ccl! adhesion. The origin of these
antibodies is indicated in the text.
during incubation both for flow cytometry analysis and adhesion
inhibition experiments. Rabbit polyclonal anti-p5 antibodies were
from Novus Molecular (San Diego, CA, USA). Biotinylated goat
anti-mouse IgG and anti-rabbit IgG were respectively from Im-
munotech and from Novus Molecular.
Matrix components
Human vitronectin was purchased from Becton Dickinson
(Bedford, MA, USA), human fibronectin from Sigma (St. Louis,
MO, USA). According to the manufacturer, both proteins were
purified to homonogeneity (> 95%) as assessed by SDS PAGE
analysis. Von Willebrand factor (vWf) was purified to homogene-
ity as described [31]. Purified vWf was homogeneous (> 95%) and
vitronectin was not detectable by SDS PAGE analysis.
Human mesangial cells
Human mesangial cells (HMC) were prepared from the normal
pole of kidney obtained after nephrectomy as previously described
[32]. Briefly, each kidney was decapsulated, glomeruli were iso-
lated from renal cortex by serial sieving, treated with collagenase
type IV 300 UI/mi (Sigma) 20 to 30 minutes at 37°C, washed, and
cultured in flasks with RPMI 1640 (ATGC, Paris, France) sup-
plemented with 10% heat-inactivated fetal bovine serum FBS
(ATGC), 2 mi L-glutamin, 60 UI/mi penicillin, 60 UI/mI strep-
tomycin, and 10 mivi HEPES at 37°C under 5% CO2. HMC grown
from giomeruli within two to three weeks were then subcultured
and maintained in 10% FBS/RPMI medium. HMC were shown to
be free of mycoplasma and characterized by morphology, a
smooth muscle actin expression, absence of factor VIII expres-
sion, and used at the 5th to 8th passages.
Human endothelial cells
Human umbilical vein endotheiiai cells (HUVEC) were iso-
lated as previously described by Jaffe et al [331. HUVEC were
cultured in M-199 (ATGC, Paris, France) supplemented with
20% heat-inactivated FBS (ATGC), 2 mivi L-glutamine, 100 U/mi
penicillin, 100 xg/ml streptomycin 0,25 jxg/ml amphotericin B, 10
mM HEPES, 50 jxg/ml heparin, 20 xg/ml endothehal cell growth
factor at 37°C under 5% C02, and used after two passages.
Fibro blasts
Fibroblasts were obtained from forearm skin biopsies as de-
scribed [34] and grown in the same condition as we used for
mesangial cell culture (see above) with 20% heat-inactivated FBS.
Flow cytometiy
Expression of integrins by cultured cells in suspension was
evaluated by flow cytometry. HMC were detached from culture
flasks by trypsin (ATGC) treatment for five minutes at 37°C,
washed with RPM!, counted and resuspended in PBS containing
1% BSA and 0.1% sodium azide. A total of i05 cells were
incubated at 4°C with anti-integrin antibodies for 30 minutes,
washed three times with PBS and stained with fluorescein-
conjugated goat anti-mouse IgG. Stained cells were fixed with 1%
formaldehyde and analyzed on a FACScan flow cytometer (Bee-
ton Dickinson).
Adhesion assays
Adhesion assays were performed in 96-well plates (Costar,
Cambridge, MA, USA) coated with 50 p1/well of matrix proteins
in PBS: fibronectin (1 pg/mI), vitronectin (0.5 irg/ml), vWf (5
jxg/ml). Plates were incubated at 37°C for 60 minutes, washed
three times withphosphate-buffered saline (PBS) and unbound
sites were blocked one hour at 37°C with 1% BSA (Sigma)
previously heat-inactivated for 60 minutes at 56°C. Control wells
were coated with 1% heat-inactivated BSA. HMC were detached
from culture flasks by trypsin/EDTA treatment, and resuspended
in RPM! with 0.1% BSA. A total of IO cells were allowed to
adhere in each well at 37°C for 60 minutes. Non-adherent cells
were then removed by washing with PBS, and adherent cells were
fixed with 4% paraformaldehyde for five minutes. After rinsing
with PBS, cells were stained for five minutes with 0.5% toluidine
blue in 4% formaldehyde and rinsed with water. Cells were
solubilized with 1% SDS and quantified in a microtiter plate
reader at 630 nm. This procedure of quantitation gives values
proportional to the number of adherent cells [24]. In adhesion
inhibition experiments, cells were first preincubated for 30 min-
utes at 4°C with anti-integrin antibodies and treated thereafter as
described above. All inhibition experiments were repeated inde-
pendently, the number of which is indicated in each cases.
Immunoprecipitation
Immunoprecipitation was performed on HMC. Cells were
washed three times with PBS and surface labeled with 2 mCi/mi of
Na'25! in tubes coated with iodogen (Pierce, Rockford, IL, USA),
according to the manufacturer's instructions. After 30 minutes at
4°C, cells were washed and solubilized with 2% NP-40 in PBS
containing protease inhibitors: 2 mi PMSF, 1 mg/mI SBTI, 1000
U/ml aprotinin, 5 mt iodoacetamide and 1 xg/ml leupeptin. The
cell lysate was cleared by centrifugation for 10 minutes at 4°C and
the supernatant, precleared on normal rabbit IgG protein A-
Sepharose, was incubated with different antibodies coupled to
protein A-Sepharose for three hours at 4°C on a roller. Antigen-
antibody complexes bound to the Sepharose beads were pelleted
on a microcentrifuge and washed ten times with PBS 0.1% NP4O.
Samples were analyzed by SDS-PAGE under nonreducing condi-
tions on a 6% polyactylamide gel and radiolabeled bands visualized
0 102 io 100 101 102 i03 i04
Log fluorescence intensity
I gG 1 IgGl
1902 Hafdi et cii: Mesangial cell expression of civ integrins
A
IgGi IgGi
ccv
E
q)(3
IgGi lgGl
ccvl33 ccvl35
100 101 1 10 1 0 101 102 i0 io
Log fluorescence intensity
B
I Gi Ig l
131
Q)
E
Fig. 1. FACS analysis of a and ci5 integrins
on mesangial cells. Suspended (10) mesangial
cells were labeled by indirect
immunofluoreseence and analyzed by flow
IgGi IgGi cytometry, as described in the Methods section,
with monoclonal antibodies to integrins: (A)
5 anti-ci (AMF/7 and LM142), anti-3 (AP3),a
anti-ap3 (LM609) and anti-aj35 (P1F6)
antibodies; and (B) anti-a2 (Gi9), anti-a5 (16,
II), anti-a,, (GoI-43) and anti-a, (K 20, Lil/2)
antibodies. Cells were then stained with
fluorescein-conjugated goat anti-mouse lgG (1:
1000 dilution) and analyzed by flow cytometry.
The ordinates depicts the number of cells per
channel and the abscissa depicts the relative
fluorescence intensity in arbitrary units (log
10° 101 102 io 10° 101 102 10 10 scale). Control mouse monoclonal IgG was
Log fluorescence intensity used as control. Represntative experiment ofsix independent determinations.
by autoradiography. The molecular mass markers were myosine (200 Western blotting
kDa), -galactosidase (116 kDa), phosphorylase-b (97 Wa), bovine
serum albumin (66 kDa) and ovalbumin (45 Wa) (Biorad Lab., HMC were solubilized with 2% NP4O in PBS with the same
Paris, France). protease inhibitors as above for 30 minutes at 4°C. Proteins were
si
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Fig. 2. Immunoprecipitation of av integrins and CD44 by human mesangial and endothelial cells in culture. Subeonfluent cultures of mesangial cells (A)
and confluent cultures of endothelial cells (B) were surface radiolabeled, lyzed with detergent and subjected to immunoprecipitation as described in the
Methods section, with monoclonal antibodies directed to the cs chain (clone LM 142), f33 chain (clone AP3), 13 chain (1(20) or to the complex aI33
(LM 609) and a (PIF6) and to CD44 (J-173) used as control [501. The precipitated material (HMC, 106 cells; HUVEC, 4 < 106 cells) was analyzed
by SDS-PAGE under non-reducing conditions and exposed to x-ray film as described. Representative gel of three independent immunoprecipitations.
analyzed by electrophoresis on 7.5% polyacrylamide gel under
non-reducing conditions, and transferred to a nitrocellulose mem-
brane by electrophoresis. After saturation overnight at room
temperature with TBST (10 m'vi Tris-HC1, pH 8; 1 mivi NaN3;
0.05% Tween 20; 0.15 M NaCl) containing 10% skimmed milk,
membranes were incubated one hour at room temperature with
anti-integrin 133 or anti-135 mAbs, followed by biotinylated anti-
mouse or -rabbit IgG respectively, washed three time with TBST
and incubated with HRP-streptavidin complex (Amersham, Buck-
inghamshire, UK). The membranes were finally revealed by
chemiluminescence using an Amersham enhancing reagent ac-
cording to the manufacturer's instruction.
Statistical analysis
Results of cell adhesion inhibition assays were expressed as
means SEM of adherent cells (OD at 630 nm). Groups of
duplicates were analyzed. Comparisons were made by ANOVA
and post hoc comparisons were made by the Dunnett's test.
Results
Membrane expression
Surface expression of integrin cs/3 and csj35 was examined by
flow cytometry on suspended cells using monoclonal antibodies to
13 chain 5 chain
I II
200 —
n 116—
9 97—
66—
45—
* Mes End Fib Mes End Fib *
Fig. 3. Western blot analysis indicates that 13 and 13. chains are present on
mesangial cells. HMC, 106 cells, (Mes); HUVEC, 4 X 10 cells (End);
human cultured fibroblasts, 106 cells (Fib) were solubilized and the blots
were probed with antibodies to 133 (AP3), f3 chain of integrins (or with
control monoclonal IgGI or polyclonal rabbit lgG; data not shown) and
performed as described in the Methods section. Biotinylated molecular
mass markers (*) are analyzed on the two external lanes of the gel.
Representative gel of three independent experiments.
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Fig. 4. Mesangial cells attachment to various matrix proteins. Mcsangial
cells were allowed to attach for 60 minutes to 96-well plates, coated with
either fibroncctin (FN), vitronectin (VN) or vWf, at various concentration
(0.1 to 100 jig/mI). Adhesion assays were performed as described in the
Methods section. Results are expressed as the percentage of adherent cells
compared with the total number of cells offered. Symbols are: () BSA;() FN; (0) VN; (A) vWF.
the f3. and a., chains and to the a.,[33 and Csv135 complexes. As
shown on Figure Ia, HMC are labeled by these four mAbs, thus
showing that mesangial cells express both a.,(33 and cr(3 integrins.
In addition, 13 integrins are known to be expressed on mesangial
cells [13, 1• We confirmed these data by showing a positive
labeling with antibodies directed against a2, a and a6 chains (Fig.
ib).
Immunoprecipitation and Western blotting
To determine the molecular weight of the cs.,(33 and a.,/35
complexes identified on the cell surface, mesangial cell mem-
branes were radiolabeled with 125j and immunoprecipitated with
specific antibodies to the a,, and 133 chains and to the cs,,133 and
a,,(35 complexes. The resulting fractions were subjected to PAGE
electrophoresis and autoradiography. Endothelial cells were
treated in the same conditions, as a control. As shown in Figure
2A, antibodies to the a, and f33 chains or to the cs,,(33 complex
immunoprecipitated proteins with molecular weight of 97 kDa
and 140 kDa, corresponding to the known molecular weights of 133
and a,, subunits, respectively. Immunoprecipitation of a,, and 133
chains from mesangial cells produced bands identical to that
observed with endothelial cells (Fig. 2B). In addition to a and 133
chains, the anti-a, antibody precipitated, on mesangial cells (as
well as on endothelial cells), a third band with an apparent
molecular weight of 115 kDa, which may correspond to the (3
chain. The antibody to a,(35 complex, which binds to mesangial
cells as assessed by FACS analysis, failed to immunoprecipitate
this integrin (Fig. 2A). 135 chain expression was nevertheless
—_
Fig. 5. Specific inhibition of mesangial cell attachment to flbronectin by
anti-integrin a5 and antibodies. Ninety-six-well plates were coated with
fibronectin at 1 jig/mI and unbound sites were blocked with BSA. Cells
were preineuhated for 30 minutes with anti a, (clone 16), anti-a,(3,
(LM609), anti-a, (Gi9), anti-a3 (P1B5) and anti-a5 + anti-(31 (Lia 1/2).
Adhesion assay was then performed as described in the Methods Section.
Results are expressed as percentage of adherent cells compared with the
control in presence of a murine monoclonal IgGi. Each point represents
the mean SIM of the number of experiments (N is indicated for each
antibody tested). *JJ < 0.05 versus control.
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Fig. 6. Specific inhibition of mesangial cell attachment to vitronectin by
anti-integrin a,f3? and aj35. Vitronectin at 0.5 jig/mI was placed into
96-well plates and non specific sites were blocked with BSA. Cells were
preincuhated for 30 minutes with anti-a,3, (LM609), anti-a,135 (P1F6),
anti-a5 (16), anti-fl1 (Lil/2). Adhesion assay was performed as described
in Methods. Results are expressed as percentage of adherent cells
compared with the control in presence of murine monoclonal IgGt. Each
point represents the mean SEM of the number of experiments (N is
indicated for each antibody tested). *p < 0.05 versus control, #P < 0.05
versus control and versus inhibition with anti-a,/3, alone.
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complex and aj35 complex (data not shown) or to a2, a3 and a6
chains had any effect on cell adhesion to fibronectin. These results
demonstrate that mesangial cell adhesion to fibronectin was
mainly mediated by the aj31 integrin.
Adhesion to vitronectin. As shown in Figure 6, mesangial cell
adhesion was inhibited by pre-incuhation with mAb to al33 or to
the af35 complexes. When used in combination, these two
antibody showed a significant additive effect and strongly inhibited
cell adhesion by about 75%. In contrast, mAbs to a5 had no effect
on adhesion to vitronectin. Anti-a2, a3, a6 chains also had no
effect (data not shown). The slight inhibition of cell adhesion by
anti-/31 mAb was not stastistically significant and was not additive
to that observed with anti-aI33 and anti-aI35. These results
demonstrate that adhesion of HMC to vitronectin was primarily
mediated by af33 and a/35 integrins.
Adhesion to von Willebrand factor. Figure 7 shows that mesan-
gial cell adhesion to von Willebrand factor was reduced by about
46% by pre-incubation with antibody to the a/33. Antibody to
csj35 complexes resulted in about 40% inhibition of cell attach-
ment. These results demonstrate that mesangial cell adhesion to
von Willebrand factor involves aI33 and aP5.
We have demonstrated by flow cytometry and immunoprecipi-
tation that af33, a broadly distributed integrin (particularly on
endothelium, smooth muscle cells and fibroblasts [21),isexpressed
on HMC and plays a role in mesangial cell adhesion to vitronectin
and vWf. The absence of a.j33-mediated binding to fibronectin,
observed in this study with HMC, is analogous to that observed
with human umbilical vein endothelial cells [25], but differs from
human dermal microvascular endothelial cells, which bind to
fibronectin through af33 [36]. One may hypothesize that the
interaction between fibronectin and aP3 is not detected on HMC,
because its strength is negligible as compared with that of a51.
al35 is also present on HMC, as shown by flow cytometry. aI35
was not detected after immunoprecipitation, probably because of
the lack of sensitivity of this method and the low amount of aJ35
present on HMC in culture. Conversely, its presence was directly
demonstrated by Western blotting after amplification by chemi-
luminescence. aP5 on HMC binds mainly to vitronectin, as
already shown for other cell types such as fibroblasts and carci-
noma cells [2, 10]. We observed that aj35on HMC interacts with
vWf, since addition of a monoclonal antibody to the a/3s complex
is inhibitory and increases the inhibition of cell attachment
observed with a monoclonal antibody to the aj33 complex. This
differs from previous reports, which demonstrated that al35
purified from placenta binds to vitronectin, marginally to fi-
bronectin but not to vWf [10], and that a lung adenocarcinoma
cell line expressing a/35 but not cc/33 binds to vitronectin but not
to fibronectin or to vWf. This apparent discordance with our
results on HMC may be due to the fact that the aI35-vWf
interaction is weak and not sufficient to promote adhesion to vWf
by itself in these models. Our results suggest that a135 on HMC
interacts with vWf and could play a role by increasing the strength
of a/33-mediated cell attachment to vWf.
Finally, ccl31 is likely to be present since we observed that the J3
chain coprecipitated with the a chain. aj31 has a more restricted
distribution, limited to few cell types including fibroblasts, than
a33, and it binds to vitronectin and fibronectin on those cells [2,
9, 37). By contrast with what was observed on fibroblasts, we
Fig. 7. Specific inhibition of mesangial cell attachment to von willebrand
factor by anti-integrin aj3? and nj35. Von Willebrand factor at 5 1Lg/ml was
placed into 96-well plates and nonspecific sites were blocked with BSA.
Cells were preincubated for 30 minutes with anti-af33 (LM609), anti-aI35
(P1F6), a (16), f3 (Lil/2). The adhesion assay was performed as
described in the Methods section. Results are expressed as percentage of
adherent cells compared with the control in presence of murine monoclo-
nal IgGI. Each point represents the mean SEM of the number of
experiments (N is indicated for each antibody tested). *p < 0.05 versus
control.
demonstrated by Western blot revealed with an polyclonal anti-
body to the f3 chain, as shown on Figure 3. The molecular weight
of the f35 chain was analogous to that of 33 chain, as already
known [10]. In this Western blot analysis (Fig. 3), HUVEC and
cultured human fibroblasts, used as control cells, expressed re-
spectively aj33 and both aj33 and aj35, as already known [2].
Role of integrins in HMC adhesion to fibronectin, vitronectin and
Mesangial cells were seeded, in the absence of serum, on
fibronectin, vitronectin or vWf coated 96-wells plates. Cell adhe-
sion occurred in a dose dependent manner. As shown in Figure 4,
60% of the maximal response was observed at concentrations of
about I jxg/ml for fibronectin, 0.5 xg/ml for vitronectin and 5
jxg/ml for vWf. Maximal adhesion was 100% of the offered cells on
fibronectin or vitronectin and 80% on vWf. Adhesion experiments
performed in the presence of 10% FBS led to similar results to
those obtained in the absence of serum. In order to determine
which integrins were involved in adhesion to these ligands, we
performed inhibition experiments with blocking anti-integrin an-
tibodies. In the following experiments, ascites fluid containing
mAbs or purified mAbs were used at a concentration equal or up
to five times the concentration, giving the maximal signal in flow
cytometry and equal or up to two times the concentration giving
the maximal adhesion inhibition in preliminary experiments.
Adhesion to fibronectin. As shown in Figure 5, mesangial cell
adhesion to fibronectin was strongly inhibited ( 75% inhibition)
by pre-incubation with mAb to the a5 or to the f3 chain alone and
with a mixture of both mAbs. In contrast, neither mAb to ai33
1906 Hafdi et a!: Mesangial cell expression of av integrins
showed that present on human cultured mesangial cells is
probably marginally important for fibronectin binding, since a
monoclonal antibody to the a5 chain almost completely inhibited
the binding to fibronectin, as already shown by others [13].
Furthermore, cs13, did not play an important role in adhesion to
vitronectin since the antibody to the 13 chain had a limited (and
not significant) effect on cell attachment to vitronectin. Thus, this
slight and not significant inhibition observed with the anti-131 mAb
precluded any firm conclusion on the eventual role of 13 integrins
during adhesion to vitronectin.
The presence of integrins of the a, family on mesangial cells
may have a number of physiopathological consequences. Modifi-
cations of this integrin expression have been reported in glomer-
ular diseases [38]. During mesangial proliferation in IgA nephrop-
athy, the av133 mesangial expression was shown to be increased
when using polyclonal Abs [18, 39, 40], or to be decreased when
using mAbs (N. Patey, personnal communication). In human
crescentic GN, we and others have observed that among other
integrins, csvPs was strongly expressed by the epithelial crescentic
cells [17, 41]. Mesangial cells are in close contact with the basal
site of endothelial cells [42]. vWf is expressed by all renal tissue
endothelial cells, is up-regulated during early fibrosis, and cob-
calized with TSP in vasculitis, diabetic nephropathy, focal sclerosis
and membranous GN, but not in minimal change or IgA nephrop-
athies [16]. On the other hand, other ligands of the a, integrin
family are also present within the gbomerulus and are modified
during gbomerulonephritis. Indeed, thrombospondin [16, 43, 44],
and osteopontin [24, 45] are synthetized by mesangial cells, and
vitronectin cobocalizes with the complement membrane attack
complex in glomerular diseases [46, 47].
One may hypothesize that, in vivo, excretion of the vWf at the
basal site of endothelial cells [211 and vitronectin deposition [48]
would promote, mainly via an interaction with a.j35, not only cell
adhesion but also migration and cells proliferation. Indeed, a133
has multiple functions possibly related to this potential mecha-
nism and, in addition to adhesion, migration and cell survival,
af33 may also play a role in phagocytosis of apoptotic cells in the
inflammed glomerulus. This function of a/33 has been demon-
strated for macrophages but remain to be studied in mesangial
cells, which are also able to phagocytize apoptotic neutrophils
[49].
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